HDL Apomics

HDL Apomics

Biotechnology-Research

Asbury Park, NJ
Company Tagline

Molecular Phenotyping for the 21st Century

Industry Category
Biotechnology-Research
Company Description

HDL Apomics is at the forefront of biotechnology research, driving innovation in molecular phenotyping for the 21st century. Located in Asbury Park, NJ, HDL Apomics is dedicated to advancing the understanding and application of cutting-edge biotechnological solutions. Their primary address is Asbury Park, NJ 07712, US.

HDL Apomics is committed to delivering high-quality research and development, contributing to significant advancements in the field. Through their work, HDL Apomics aims to improve outcomes and set new standards in the biotechnology industry. The company focuses on pioneering research to tackle complex challenges and create impactful solutions.

With a forward-thinking approach, HDL Apomics continues to expand its capabilities and broaden its reach. We encourage the management of HDL Apomics to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and innovations.

Key Personnel / Employees
Scott Altmann PhD

Similar Companies

Other organizations in the same industry

ALZpath Inc.
Biotechnology-Research

Accelerating Novel Diagnostic Solutions for Alzheimer's Disease

Carlsbad, California
United States
Spinogenix, Inc.
Biotechnology-Research

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases

Los Angeles, Califor...
United States
Amydis, Inc.
Biotechnology-Research

Developing a New Class of Molecular Diagnostics and Digital Biomarkers for the Eye to Diagnose & Mon...

San Diego, CA
United States
HUMINTECH GmbH
Biotechnology-Research

Humic Substances Based Biostimulants. Made in Germany. Successful all over the world.

Grevenbroich, Nordrh...

Alternative Company Names

This company is also known as

HDL Apomics